PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surg…
Medical - Devices
US, Redwood City [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 11.58 | 8.52 | 7.63 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -13.57 | 5.45 | 6.30 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | -6.73 | 5.18 | 5.55 | |
| Cash | -13.03 | 4.42 | 5.08 | |
| Capex | 77.86 | -0.04 | -0.17 | |
| Free Cash Flow | -1.32 | -0.67 | -0.66 | |
| Revenue | 1.35 | 0.87 | 0.86 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | 22.86 | 0.56 | 0.46 | |
| Operating Margin | 8.47 | -0.62 | -0.68 | |
| ROA | 0.25 | -0.07 | -0.07 | |
| ROE | -0.35 | -0.10 | -0.10 | |
| ROIC | 7.69 | -0.09 | -0.09 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of PRCT is permitted for members.
5
Growth
The "Growth Entry" for the Focus of PRCT is permitted for members.
6
Leverage & Liquidity